3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Neoplasms
1
Hemorrhage
1
Endometriosis
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
Sunitinib
86
Sorafenib
60
Everolimus
47
pazopanib
46
Bevacizumab
46
Nivolumab
44
pembrolizumab
37
aldesleukin
29
Interferon-alpha
26
Axitinib
24
temsirolimus
23
cabozantinib
20
Interleukin-2
19
Ipilimumab
16
Interferon alpha-2
15
Cyclophosphamide
15
fludarabine phosphate
14
Gemcitabine
14
Peripheral Blood Stem Cell Transplantation
11
Sirolimus
10
Paclitaxel
10
Erlotinib Hydrochloride
10
avelumab
8
Radiosurgery
8
Docetaxel
8
Cyclosporine
8
Capecitabine
8
tremelimumab
7
lenvatinib
7
Mycophenolic Acid
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Renal Cell
×
Sutures
×
Clear all
NCT07232927
2025-11-18
HEMOSTA-PN
Ankara University
Phase NA
Completed
150 enrolled